Skip to content

A study to understand the effect of external application of Ksheeridruvalkadi paste in the patients with crack foot

Clinical Trial to Evaluate the Efficacy of Ksheeridruvalkadi Lepa in the Management of Padadari - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/02/080436
Enrollment
30
Registered
2025-02-12
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L988- Other specified disorders of the skin and subcutaneous tissue

Interventions

None listed

Sponsors

NIL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Subjects having cracks/fissures in the feet with or without pain and/or itching will be selected. 2. Subjects between the age of 18 and 60 years irrespective of gender and socio-economic status. 3. Subjects who are willing to sign the consent form and agreeing to follow the protocol of the study

Exclusion criteria

Exclusion criteria: 1. Subjects with Skin diseases as secondary manifestations to systemic illness. 2. Subjects suffering from psoriasis, eczema, allergic conditions. 3. Subjects having Cellulitis or ulcers in the foot, discharge from cracks and suppurative infections 4. Pregnant women and lactating mothers.

Design outcomes

Primary

MeasureTime frame
â?¢ To determine the efficacy of Ksheeridruvalkadi Lepa in reducing the pain associated with Padadari. â?¢ To determine the efficacy of Ksheeridruvalkadi Lepa in reducing the number of cracks.Timepoint: Subjective parameters: â?¢ Pain â?¢ Itching â?¢ Dryness Objective parameters: â?¢ Number of fissures â?¢ Average length of fissures â?¢ Average depth of fissures Assessment will be done on 0th day, 8th day, 15th day and 30th day Investigations: Laboratory tests will be performed on 0th day which includes: â?¢ Fasting Blood Sugar â?¢ Blood Routine Examination with Erythrocyte Sedimentation Rate

Secondary

MeasureTime frame
To assess the safety of Ksheeridruvalkadi Lepa in SubjectsTimepoint: â?¢ Absolute Eosinophil Count â?¢ Renal Function Test â?¢ Liver Function Test Tests will be performed on 0th day and 15th day â?¢ Contact Allergy Test will be performed on 0th day

Countries

India

Contacts

Public ContactDr Arya Kallia K K

Pankajakasthuri Ayurveda Medical College & Post Graduate Centre, Kattakada, Thiruvananthapuram.

aryakrishnaraj99@gmail.com9497155753

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026